nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Anti-IL-2-R monoclonal antibody in allograft recipients
|
Soulillou, J.P. |
|
1988 |
1 |
6 |
p. 655-661 7 p. |
artikel |
2 |
Approach to the use of antigen non-specific immunosuppression in systemic lupus erythematosus and other rheumatic autoimmune diseases
|
Steinberg, Alfred D. |
|
1988 |
1 |
6 |
p. 575-592 18 p. |
artikel |
3 |
A theoretical framework for self-tolerance and its relevance to therapy of autoimmune disease
|
Waldmann, Herman |
|
1988 |
1 |
6 |
p. 623-629 7 p. |
artikel |
4 |
Autoimmunity: the moving boundaries between physiology and pathology
|
Huetz, François |
|
1988 |
1 |
6 |
p. 507-518 12 p. |
artikel |
5 |
Cancer is a long-term hazard of immunosuppressive therapy
|
Penn, Israel |
|
1988 |
1 |
6 |
p. 545-558 14 p. |
artikel |
6 |
Cellular mechanisms in immune tolerance and treatment of autoimmune disease: Studies using total lymphoid irradiation (TLI)
|
Strober, Samuel |
|
1988 |
1 |
6 |
p. 693-702 10 p. |
artikel |
7 |
Clinical use of OKT3: The role of cytokine release and xenosensitization
|
Chatenoud, Lucienne |
|
1988 |
1 |
6 |
p. 631-640 10 p. |
artikel |
8 |
Cyclosporine A and the regulation of autoimmune disease
|
Lafferty, Kevin J. |
|
1988 |
1 |
6 |
p. 519-532 14 p. |
artikel |
9 |
Hazards of cyclosporine a therapy and recommendations for its use
|
Mihatsch, Michael J. |
|
1988 |
1 |
6 |
p. 533-543 11 p. |
artikel |
10 |
Idiotype selection is an immunoregulatory mechanism which contributes to the pathogenesis of systemic lupus erythematosus
|
Hahn, Bevra H. |
|
1988 |
1 |
6 |
p. 673-681 9 p. |
artikel |
11 |
Immunointervention in skin disorders
|
Fry, Lionel |
|
1988 |
1 |
6 |
p. 593-601 9 p. |
artikel |
12 |
Induction of SLE-like disease in naive mice with a monoclonal anti-DNA antibody derived from a patient with polymyositis carrying the 16 6 ID
|
Blank, M. |
|
1988 |
1 |
6 |
p. 683-691 9 p. |
artikel |
13 |
Introduction
|
Hamburger, Jean |
|
1988 |
1 |
6 |
p. 497-498 2 p. |
artikel |
14 |
Maintenance of autoimmunity
|
Talal, Norman |
|
1988 |
1 |
6 |
p. 703-709 7 p. |
artikel |
15 |
Some viral infections and related disorders associated with long-term immunosuppressive treatments
|
Nicolas, Jean-François |
|
1988 |
1 |
6 |
p. 559-573 15 p. |
artikel |
16 |
The clinical use of immunosuppressants in the treatment of putative autoimmune intra-ocular diseases
|
Nussenblatt, Robert |
|
1988 |
1 |
6 |
p. 615-621 7 p. |
artikel |
17 |
The multichain interleukin-2-receptor: A target for immunotherapy of patients with adult T-cell leukemia, autoimmune disorders and individuals receiving allografts
|
Waldmann, Thomas A. |
|
1988 |
1 |
6 |
p. 641-653 13 p. |
artikel |
18 |
Therapeutic immunosuppression in type I (insulin-dependent) diabetes
|
Feutren, Gilles |
|
1988 |
1 |
6 |
p. 603-614 12 p. |
artikel |
19 |
Therapy of autoimmune diseases with monoclonal antibodies to class II major histocompatibility complex antigens: The role of T lymphocytes
|
Boitard, C. |
|
1988 |
1 |
6 |
p. 663-671 9 p. |
artikel |
20 |
The risk/benefit ratio in immunointervention for autoimmune diseases
|
Bach, Jean-François |
|
1988 |
1 |
6 |
p. 711-720 10 p. |
artikel |
21 |
The role of antigen in autoimmune responses with special reference to changes in carbohydrate structure of IgG in rheumatoid arthritis
|
Roitt, Ivan M. |
|
1988 |
1 |
6 |
p. 499-506 8 p. |
artikel |